Moderna completes filing process for full approval of COVID-19 vaccine

Health News
FILE PHOTO: A healthcare worker prepares a syringe with the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the COVID-19 pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar/File Photo

(Reuters) – Moderna Inc has completed the real-time review process for its application to the U.S. Food and Drug Administration (FDA) seeking full approval for its COVID-19 vaccine in people aged 18 years and above, the company said on Wednesday.

As part of the completed submission, Moderna has requested a priority review designation for its vaccine.

Source: Read Full Article

Related posts:

U.S. reviewing if Moderna shot tied to higher heart inflammation risk – Washington Post U.S. CDC says schools in low COVID-19-transmission areas can fully reopen with mask-wearing, mitigation Alabama extends mask mandate for a month, breaking with Texas, Mississippi White House to Florida, Texas leaders: Help on COVID-19 or 'get out of the way' U.S. administers 356.4 million doses of COVID-19 vaccines – CDC
, , , ,